Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 24;143(11):4085-4089.
doi: 10.1021/jacs.0c11837. Epub 2021 Mar 12.

The Effects of Sodium Ions on Ligand Binding and Conformational States of G Protein-Coupled Receptors-Insights from Mass Spectrometry

Affiliations

The Effects of Sodium Ions on Ligand Binding and Conformational States of G Protein-Coupled Receptors-Insights from Mass Spectrometry

Mark T Agasid et al. J Am Chem Soc. .

Abstract

The use of mass spectrometry to investigate proteins is now well established and provides invaluable information for both soluble and membrane protein assemblies. Maintaining transient noncovalent interactions under physiological conditions, however, remains challenging. Here, using nanoscale electrospray ionization emitters, we establish conditions that enable mass spectrometry of two G protein-coupled receptors (GPCR) from buffers containing high concentrations of sodium ions. For the Class A GPCR, the adenosine 2A receptor, we observe ligand-induced changes to sodium binding of the receptor at the level of individual sodium ions. We find that antagonists promote sodium binding while agonists attenuate sodium binding. These findings are in line with high-resolution X-ray crystallography wherein only inactive conformations retain sodium ions in allosteric binding pockets. For the glucagon receptor (a Class B GPCR) we observed enhanced ligand binding in electrospray buffers containing high concentrations of sodium, as opposed to ammonium acetate buffers. A combination of native and -omics mass spectrometry revealed the presence of a lipophilic negative allosteric modulator. These experiments highlight the advantages of implementing native mass spectrometry, from electrospray buffers containing high concentrations of physiologically relevant salts, to inform on allosteric ions or ligands with the potential to define their roles on GPCR function.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following competing financial interest(s): JY is an employee of Novo Nordisk, a pharmaceutical company focused on class B GPCRs for type 2 diabetes. CVR is a cofounder and Director of OMass Therapeutics.

Figures

Figure 1
Figure 1
Ligand dependent effects on the sodium bound states of A2aR. (A) Schematic illustrating the sodium binding pocket of A2aR in an inactive conformation (PDB 4EIY) and the collapse of the pocket upon adopting an active conformation (PDB 3QAK). 13+ charge state of A2aR electrosprayed from (B) 200 mM NH4OAc and (C) 50 mM NaCl, 5 mM Tris (both pH 7.5 with 2× CMC LMNG) in the absence or presence of 10 μM ligand. Spectra are representative of n ≥ 4 nanoemitters and 2 protein preparations.
Figure 2
Figure 2
Preservation of lipophilic drug binding to the glucagon receptor in NaCl-containing electrospray buffers. (A) Structure of the full-length glucagon receptor (PDB 5XEZ) showing the allosteric binding pocket binding NNC0640, a variant of to NNC0666, situated between transmembrane loops VI and VII with interacting residues highlighted in blue. Native mass spectra of GCGR released from G1/CHS micelles in (B) 250 mM NH4OAc, pH 7.5 electrospray buffer or (C) 50 mM NaCl, 5 mM Tris, pH 7.5 electrospray buffers with insets expanding the 13+ charge state. Differences in binding of the NNC066 are more prevalent in (C), highlighted orange and red for one and two NAMs, respectively. Spectra are representative of n ≥ 4 nanoemitters and n = 2 protein preparations.

Similar articles

Cited by

References

    1. Santos R.; Ursu O.; Gaulton A.; Bento A. P.; Donadi R. S.; Bologa C. G.; Karlsson A.; Al-Lazikani B.; Hersey A.; Oprea T. I.; Overington J. P. A comprehensive map of molecular drug targets. Nat. Rev. Drug Discovery 2017, 16 (1), 19–34. 10.1038/nrd.2016.230. - DOI - PMC - PubMed
    1. van der Westhuizen E. T.; Valant C.; Sexton P. M.; Christopoulos A. Endogenous Allosteric Modulators of G Protein-Coupled Receptors. J. Pharmacol. Exp. Ther. 2015, 353 (2), 246–260. 10.1124/jpet.114.221606. - DOI - PubMed
    1. Katritch V.; Fenalti G.; Abola E. E.; Roth B. L.; Cherezov V.; Stevens R. C. Allosteric sodium in class A GPCR signaling. Trends Biochem. Sci. 2014, 39 (5), 233–244. 10.1016/j.tibs.2014.03.002. - DOI - PMC - PubMed
    1. Vickery O. N.; Carvalheda C. A.; Zaidi S. A.; Pisliakov A. V.; Katritch V.; Zachariae U. Intracellular Transfer of Na+ in an Active-State G-Protein-Coupled Receptor. Structure 2018, 26 (1), 171–180. 10.1016/j.str.2017.11.013. - DOI - PMC - PubMed
    1. White K. L.; Eddy M. T.; Gao Z. G.; Han G. W.; Lian T.; Deary A.; Patel N.; Jacobson K. A.; Katritch V.; Stevens R. C. Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling. Structure 2018, 26 (2), 259–269. 10.1016/j.str.2017.12.013. - DOI - PMC - PubMed

Publication types

LinkOut - more resources